The Molecular Therapy: Nucleic Acids is reputed journal publishes research related to vector development, rna based therapeutics, gene modifying agents. The ISSN of the journal is .
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | Molecular Therapy: Nucleic Acids |
|---|---|
| Publisher | Elsevier |
| Publication Country | United States |
| ISSN | |
| Publication Area | Medicine: Therapeutics. Pharmacology |
| Publication Language | English |
| Review Process | Anonymous peer review |
| Scopus Indexed | No |
The Impact Factor of Molecular Therapy: Nucleic Acids in 2026 is 6.5.
The Molecular Therapy: Nucleic Acids is ranked in Q1.
The Molecular Therapy: Nucleic Acids is indexed in: DOAJ, Web of Science.
There is a fee to publish in the Molecular Therapy: Nucleic Acids. The publication fee is 3900 USD.
The journal also offers a fee waiver policy.
The Molecular Therapy: Nucleic Acids takes an average of 23 weeks to publish research papers.
The official website of the journal is https://www.sciencedirect.com/journal/molecular-therapy-nucleic-acids.
Please visit only official website of the journal to submit research papers.